PSY
Defiance Next Gen Altered Experi
PSY
5,90
0,00 Bil. AUM
0,8% Expense Ratio
5,93 NAV
Defiance Next Gen Altered Experi Profile
About Defiance Next Gen Altered Experi
The index is a rules-based index that tracks the performance of a portfolio of companies conducting legal activities under the national laws of the applicable country related to medical psychedelics, medical cannabis, cannabis pharmaceuticals and cannabidiol derivatives, and ketamine. The fund uses a “replication” strategy to achieve its investment objective, it will invest in all of the component securities of the index in the same approximate proportions as in the index. It is non-diversified.
- Company
- Holdings
- 2
- CUSIP
Defiance Next Gen Altered Experi Sectors
| Industry | Percentage |
|---|---|
| Healthcare | 82,68% |
| Consumer Cyclica | 6,43% |
| Consumer Defensi | 5,65% |
| Real Estate | 5,25% |
| Basic Materials | 0,00% |
| Technology | 0,00% |
| Industrials | 0,00% |
| Financial Servic | 0,00% |
| Energy | 0,00% |
| Communication Se | 0,00% |
| Utilities | 0,00% |